Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Dhruv Singhal
Metabolic regulation and obesity caused by overeating are thought to be major risk factors for breast cancer. Both obesity and breast cancer can be traced back to early stages of human development. A natural is flavone found in soybean products called genistein (GE) has been linked to a lower risk of breast cancer and other metabolic disorders. Our review expected to decide the impacts of maternal openness to soybean dietary GE on avoidance of over nutrition-prompted bosom malignant growth further down the road and investigate possible components in various mouse models. By significantly reducing the high-fat diet-induced body fat accumulation, lipid panel abnormalities, and glucose intolerance in the offspring of mice, our findings demonstrated that maternal dietary GE treatment improved metabolic functions in the offspring. Importantly, exposure to GE in the mother’s diet effectively delayed the development of female offspring’s simulated mammary tumors caused by a high-fat diet. We discovered that, at least partially through regulation of the offspring’s gut microbiome, bacterial metabolites, and epigenetic profiles, maternal GE may exert its chemo preventive effects by affecting essential regulatory gene expression in control of metabolism, inflammation, and tumor development. Through dynamically influencing the interaction between early-life gut micro biota, key microbial metabolite profiles, and offspring epigenome, our findings suggest that maternal GE consumption is an effective intervention approach leading to early-life prevention of obesity-related metabolic disorders and breast cancer later in life.